EUVIMEDEUVIMED entdecken
Open Access

Open-Label, Single-Center, Single-Arm Study Evaluating the Efficacy and Safety of Elobixibat for Chronic Constipation in Patients With Heart Failure

Koichiro Fujisue, Miwa Ito, Yasushi Matsuzawa, Yuichiro Arima, Seiji Takashio, Daisuke Sueta, Satoshi Araki, Shinsuke Hanatani, Kenshi Yamanaga, Masahiro Yamamoto, Shozo Kaneko, Eiichiro Yamamoto und 3 weitere

Circulation Reports · 08.03.2024 · 6 (3) · 55-63

DOI: 10.1253/circrep.cr-23-0099 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Circulation Reports, erschienen am 08.03.2024. Verfasst von Koichiro Fujisue und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University Kumamoto Japan. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Neither the efficacy nor safety of elobixibat has been investigated in the treatment of chronic constipation in patients with heart failure (HF). Methods and Results: In this prospective, single-center, single-arm study elobixibat (10 mg/day) was administered for 12 weeks to 18 HF patients with chronic constipation defined according to the Rome IV criteria. Spontaneous bowel movement (SBM), stool consistency as measured by the Bristol Stool Form Scale, and degree of straining during defecation were recorded. In addition, biomarkers, blood pressure (BP) measured by ambulatory monitoring, and adverse events were assessed. Although there was no significant difference, the frequency of SBM increased by 2.0/week from baseline to Week 12. Both the degree of straining during defecation and low-density lipoprotein cholesterol (LDL-C) levels were significantly decreased at Week 12 (straining, -0.79 [95% confidence interval (CI), -1.40 to -0.17]; LDL-C, -10.4 mg/dL [95% CI, -17.9 to -2.9]). Although not significant, the difference in BP before and after defecation tended to decrease from baseline by approximately 10 mmHg at Week 12. Serious adverse events were not observed.

Conclusions

Elobixibat reduced the degree of straining during defecation, and improved the lipid profile in HF patients with chronic constipation.

Schlagwörter

Stichwörter der Autor:innen

Chronic constipationDefecationElobixibatHeart failure

Autor:innen und Institutionen

  • Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University Kumamoto Japan.
  • Miyazaki Medical Association Hospital Miyazaki Japan.
  • Department of Cardiology, Saitama Medical University International Medical Center Hidaka Japan.

Zitieren

APA

Fujisue, K., Ito, M., Matsuzawa, Y., Arima, Y., Takashio, S., Sueta, D., Araki, S., Hanatani, S., Yamanaga, K., Yamamoto, M., Kaneko, S., Yamamoto, E., Matsushita, K., Soejima, H., & Tsujita, K. (2024). Open-Label, Single-Center, Single-Arm Study Evaluating the Efficacy and Safety of Elobixibat for Chronic Constipation in Patients With Heart Failure. Circulation Reports, 6(3), 55-63. https://doi.org/10.1253/circrep.cr-23-0099

Vancouver

Fujisue K, Ito M, Matsuzawa Y, Arima Y, Takashio S, Sueta D, et al. Open-Label, Single-Center, Single-Arm Study Evaluating the Efficacy and Safety of Elobixibat for Chronic Constipation in Patients With Heart Failure. Circulation Reports. 2024;6(3):55-63. doi:10.1253/circrep.cr-23-0099

BibTeX
@article{Fujisue2024,
  author = {Fujisue, Koichiro and Ito, Miwa and Matsuzawa, Yasushi and Arima, Yuichiro and Takashio, Seiji and Sueta, Daisuke and Araki, Satoshi and Hanatani, Shinsuke and Yamanaga, Kenshi and Yamamoto, Masahiro and Kaneko, Shozo and Yamamoto, Eiichiro and Matsushita, Kenichi and Soejima, Hirofumi and Tsujita, Kenichi},
  title = {Open-Label, Single-Center, Single-Arm Study Evaluating the Efficacy and Safety of Elobixibat for Chronic Constipation in Patients With Heart Failure},
  journal = {Circulation Reports},
  year = {2024},
  volume = {6},
  number = {3},
  pages = {55--63},
  doi = {10.1253/circrep.cr-23-0099}
}
Kostenlos starten →